Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial. Read more about Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.
Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Read more about Identifying molecular phenotypes in sepsis: an analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials.
Is neutrophilic inflammation treatable in COVID-19? Read more about Is neutrophilic inflammation treatable in COVID-19?
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study. Read more about Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study.
Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research. Read more about Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research.
Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis. Read more about Validation and utility of ARDS subphenotypes identified by machine-learning models using clinical data: an observational, multicohort, retrospective analysis.
Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis. Read more about Identification of phenotypes in paediatric patients with acute respiratory distress syndrome: a latent class analysis.
Advancing precision medicine for acute respiratory distress syndrome. Read more about Advancing precision medicine for acute respiratory distress syndrome.
Geography, generalisability, and susceptibility in clinical trials. Read more about Geography, generalisability, and susceptibility in clinical trials.
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study. Read more about Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational study.
